Climacteron

Climacteron
Combination of
Estradiol benzoate Estrogen
Estradiol dienanthate Estrogen
Testosterone enanthate benzilic acid hydrazone Androgen/anabolic steroid
Clinical data
Trade names Climacteron
Routes of
administration		 Intramuscular injection
Identifiers
CAS Number
PubChem CID

Climacteron is a combination formulation of 1.0 mg estradiol benzoate, 7.5 mg estradiol dienanthate, and 150 mg testosterone enanthate benzilic acid hydrazone (69 mg testosterone base) which is used in the treatment of menopausal symptoms in postmenopausal women.[1][2] It is administered by intramuscular injection and is given once every 4 to 8 weeks or less frequently.[1]

See also

References

  1. 1 2 https://www.drugs.com/mmx/climacteron.html
  2. ↑ Sherwin BB (1988). "Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women". Psychoneuroendocrinology. 13 (4): 345–57. doi:10.1016/0306-4530(88)90060-1. PMID 3067252.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.